“…The beneficial effects of several flavonol glycosides have been demonstrated in relation to diabetes mellitus, through acting at multiple sites of glucose regulatory pathways, e.g. glucose tolerance, lipid profile, glycogen biosynthesis, glucose uptake and insulin release (Sharma et al, 2008;Cazarolli et al, 2009). Although many bioactivities of the principal constituent, transtiliroside were reported, such as hepatoprotective inhibition of the production of nitric oxide and tumor necrosis factor-␣ in macrophages, inhibition of human low density lipoprotein oxidation (Schinella et al, 2007), anti-obese (Ninomiya et al, 2007), anti-inflammatory (Sala et al, 2003) and anticomplement activities .…”